Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice
Open Access
- 22 August 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 8 (11) , 3923-3931
Abstract
Microdosing, the prolonged ingestion of psychedelics at subhallucinogenic doses, has gained popularity for its perceived cognitive and emotional benefits. Psychedelics have high affinity for 5-HT2B receptors, a receptor known to cause human heart disease with strong chronic activation. We investigated the effects of microdosed psychedelics on cardiovascular health in mice using echocardiography after chronically administering either serotonin or d-fenfluramine as positive controls or lysergic acid diethylamide (LSD) at two subhallucinogenic doses. Serotonin produced significant ventricular thickening at 4- and 8-weeks, and d-fenfluramine caused aortic valve regurgitation at 4-weeks. No significant changes were observed in any vehicle or LSD group. We determined the affinity and potency of LSD, psilocybin, and norfenfluramine at mouse and human 5-HT2BRs and observed no significant differences. We calculated that levels of 5-HT2B activation by low-dose LSD were substantial, but short-lived, compared to the cardiotoxin d-fenfluramine. Together, these data provide no evidence of ventricular or valvular remodeling associated with prolonged administration of low-dose LSD in mice.Keywords
All Related Versions
Funding Information
- Clinical Center (R01DA061433)
- NIH Office of the Director (1S10OD034423-01)
This publication has 36 references indexed in Scilit:
- State Cannabis and Psychedelic Legislation and Microdosing Interest in the USJAMA Health Forum, 2024
- The Rise of Psychedelic Drug Use Associated With Legalization/Decriminalization: An Assessment With the Nonmedical Use of Prescription Drugs SurveyAnnals of Emergency Medicine, 2023
- Emerging Challenges for Psychedelic TherapyJAMA Psychiatry, 2023
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use DisorderJAMA Psychiatry, 2022
- Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy ParticipantsClinical Pharmacology & Therapeutics, 2020
- Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other speciesNeuropharmacology, 2020
- Characterization of the head-twitch response induced by hallucinogens in micePsychopharmacology, 2013
- Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humansExperimental and Toxicologic Pathology, 2010
- Histologic Changes in Three Explanted Native Cardiac Valves Following Use of FenfluraminesCardiovascular Pathology, 1999
- Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.The Journal of Pharmacology and Experimental Therapeutics, 1996